Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Use of 18F FDG PET: A Systematic Review

被引:133
作者
Kwee, Robert M. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, NL-6202 AZ Maastricht, Netherlands
关键词
POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; ESOPHAGOGASTRIC JUNCTION; PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMORADIATION; METABOLIC-ACTIVITY; INDUCTION CHEMORADIATION; COMPUTED-TOMOGRAPHY; FREE SURVIVAL;
D O I
10.1148/radiol.09091324
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To systematically review the accuracy of fluorine 18 ((18) F) fluorodeoxyglucose (FDG) positron emission tomography (PET) in the prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer. Materials and Methods: The MEDLINE and EMBASE databases were systematically searched for relevant studies. Methodologic quality of the included studies was assessed. Sensitivities and specificities of F-18 FDG PET in individual studies were calculated and underwent meta-analysis with a random effects model. A summary receiver operating characteristic curve (sROC) was constructed with the Moses-Shapiro-Littenberg method. A chi(2) test was performed to test for heterogeneity (defined as P < .10). Potential sources for heterogeneity were explored by assessing whether certain covariates significantly (P < .05) influenced the relative diagnostic odds ratio. Results: Twenty reports, comprising a total of 849 patients with esophageal cancer, were included. Overall, the studies were of moderate methodologic quality. Sensitivity and specificity of F-18 FDG PET ranged from 33% to 100% and from 30% to 100%, respectively, with pooled estimates of 67% (95% confi dence interval: 62%, 72%) and 68% ( 95% confi dence interval: 64%, 73%), respectively. The area under the sROC curve was 0.7815. There was significant heterogeneity in both the sensitivity and specificity of the included studies (P < .0001). Spearman rho between the logit of sensitivity and the logit of 1-specificity was 0.086 (P = .719), which suggested that there was no threshold effect. Studies performed outside of the United States and studies of higher methodologic quality yielded significantly higher overall accuracy. Conclusion: On the basis of current evidence, 18 F FDG PET should not yet be used in routine clinical practice to guide neoadjuvant therapy decisions in patients with esophageal cancer. (C) RSNA, 2010
引用
收藏
页码:707 / 717
页数:11
相关论文
共 50 条
[41]   The accuracy of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review [J].
Fangfang Tian ;
Guohua Shen ;
Yunfu Deng ;
Wei Diao ;
Zhiyun Jia .
European Radiology, 2017, 27 :4786-4796
[42]   Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment 18F-FDG PET/CT Imaging [J].
Beukinga, Roelof J. ;
Hulshoff, Jan B. ;
van Dijk, Lisanne V. ;
Muijs, Christina T. ;
Burgerhof, Johannes G. M. ;
Kats-Ugurlu, Gursah ;
Slart, Riemer H. J. A. ;
Slump, Cornelis H. ;
Mul, Veronique E. M. ;
Plukker, John Th. M. .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) :723-729
[43]   Prognostic Value of Pretherapeutic Primary Tumor MTV from [18F]FDG PET in Radically Treated Cervical Cancer Patients [J].
Cegla, Paulina ;
Hofheinz, Frank ;
Cholewinski, Witold ;
Czepczynski, Rafal ;
Kubiak, Anna ;
van den Hoff, Joerg ;
Bos-Liedke, Agnieszka ;
Roszak, Andrzej ;
Burchardt, Ewa .
METABOLITES, 2021, 11 (12)
[44]   A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patients [J].
Bollineni, V. R. ;
Kramer, G. M. ;
Jansma, E. P. ;
Liu, Y. ;
Oyen, W. J. G. .
EUROPEAN JOURNAL OF CANCER, 2016, 55 :81-97
[45]   Prognostic Impact of [18F] FDG-PET in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy [J].
Jung, So-Youn ;
Kim, Seok-Ki ;
Nam, Byung-Ho ;
Min, Sun Young ;
Lee, Seung Joo ;
Park, Chansung ;
Kwon, Youngmee ;
Kim, Eun-A ;
Ko, Kyoung Lan ;
Park, In Hae ;
Lee, Keun Seok ;
Shin, Kyung Hwan ;
Lee, Seeyoun ;
Kim, Seok Won ;
Kang, Han-Sung ;
Ro, Jungsil .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (01) :247-253
[46]   Comparison of [18F]FDG PET/CT and CT in the response assessment and clinical outcome prediction for immunotherapy in patients with advanced melanoma: a systematic review and meta-analysis [J].
Deng, Yueling ;
Zhang, Xiao ;
Song, Yangmeihui ;
Lan, Xiaoli .
EUROPEAN RADIOLOGY, 2025,
[47]   Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis [J].
Wang, Yuting ;
Zhang, Chengpeng ;
Liu, Jianjun ;
Huang, Gang .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) :357-369
[48]   The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer [J].
Murcia Durendez, M. J. ;
Frutos Esteban, L. ;
Lujan, J. ;
Frutos, M. D. ;
Valero, G. ;
Navarro Fernandez, J. L. ;
Salem, L. Mohamed ;
Ruiz Merino, G. ;
Claver Valderas, M. A. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) :91-97
[49]   18F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy [J].
Lee, Seokmo ;
Choi, Yunseon ;
Park, Geumju ;
Jo, Sunmi ;
Lee, Sun Seong ;
Park, Jisun ;
Shim, Hye-Kyung .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
[50]   [F18] FDG-PET/CT for manual or semiautomated GTV delineation of the primary tumor for radiation therapy planning in patients with esophageal cancer: is it useful? [J].
Walter, Franziska ;
Jell, Constanze ;
Zollner, Barbara ;
Andrae, Claudia ;
Gerum, Sabine ;
Ilhan, Harun ;
Belka, Claus ;
Niyazi, Maximilian ;
Roeder, Falk .
STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (09) :780-790